These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 23808355)

  • 1. Systemic and cerebral exposure to and pharmacokinetics of flavonols and terpene lactones after dosing standardized Ginkgo biloba leaf extracts to rats via different routes of administration.
    Chen F; Li L; Xu F; Sun Y; Du F; Ma X; Zhong C; Li X; Wang F; Zhang N; Li C
    Br J Pharmacol; 2013 Sep; 170(2):440-57. PubMed ID: 23808355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal absorption and presystemic elimination of various chemical constituents present in GBE50 extract, a standardized extract of Ginkgo biloba leaves.
    Li L; Zhao Y; Du F; Yang J; Xu F; Niu W; Ren Y; Li C
    Curr Drug Metab; 2012 Jun; 13(5):494-509. PubMed ID: 22292790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human pharmacokinetics of ginkgo terpene lactones and impact of carboxylation in blood on their platelet-activating factor antagonistic activity.
    Liu XW; Yang JL; Niu W; Jia WW; Olaleye OE; Wen Q; Duan XN; Huang YH; Wang FQ; Du FF; Zhong CC; Li YF; Xu F; Gao Q; Li L; Li C
    Acta Pharmacol Sin; 2018 Dec; 39(12):1935-1946. PubMed ID: 30054600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A sensitive and selective multiple reaction monitoring mass spectrometry method for simultaneous quantification of flavonol glycoside, terpene lactones, and biflavonoids in Ginkgo biloba leaves.
    Wang LT; Fan XH; Jian Y; Dong MZ; Yang Q; Meng D; Fu YJ
    J Pharm Biomed Anal; 2019 Jun; 170():335-340. PubMed ID: 30986686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of pharmacokinetic profile of different parts from Ginkgo biloba extract in rats.
    Guan H; Qian D; Ren H; Zhang W; Nie H; Shang E; Duan J
    J Ethnopharmacol; 2014 Aug; 155(1):758-68. PubMed ID: 24953034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct analysis of 18 flavonol glycosides, aglycones and terpene trilactones in Ginkgo biloba tablets by matrix solid phase dispersion coupled with ultra-high performance liquid chromatography tandem triple quadrupole mass spectrometry.
    Liu XG; Yang H; Cheng XL; Liu L; Qin Y; Wang Q; Qi LW; Li P
    J Pharm Biomed Anal; 2014 Aug; 97():123-8. PubMed ID: 24876067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous quantification of flavonol glycosides, terpene lactones, biflavones, proanthocyanidins, and ginkgolic acids in Ginkgo biloba leaves from fruit cultivars by ultrahigh-performance liquid chromatography coupled with triple quadrupole mass spectrometry.
    Yao X; Zhou GS; Tang YP; Qian YF; Guan HL; Pang H; Zhu S; Mo X; Su SL; Jin C; Qin Y; Qian DW; Duan JA
    Biomed Res Int; 2013; 2013():582591. PubMed ID: 23533996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative characterization of total flavonol glycosides and terpene lactones at different ages, from different cultivation sources and genders of Ginkgo biloba leaves.
    Yao X; Shang E; Zhou G; Tang Y; Guo S; Su S; Jin C; Qian D; Qin Y; Duan JA
    Int J Mol Sci; 2012; 13(8):10305-10315. PubMed ID: 22949862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of biologically active components in ginkgo leaf products on the Japanese market.
    Kakigi Y; Hakamatsuka T; Icho T; Goda Y; Mochizuki N
    Biosci Biotechnol Biochem; 2011; 75(4):777-9. PubMed ID: 21512233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of food and gender on the pharmacokinetics of ginkgolides A, B, C and bilobalide in rats after oral dosing with ginkgo terpene lactones extract.
    Huang P; Zhang L; Chai C; Qian XC; Li W; Li JS; Di LQ; Cai BC
    J Pharm Biomed Anal; 2014 Nov; 100():138-144. PubMed ID: 25165009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An effective identification and quantification method for Ginkgo biloba flavonol glycosides with targeted evaluation of adulterated products.
    Ma YC; Mani A; Cai Y; Thomson J; Ma J; Peudru F; Chen S; Luo M; Zhang J; Chapman RG; Shi ZT
    Phytomedicine; 2016 Apr; 23(4):377-87. PubMed ID: 27002408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative pharmacokinetics and bioavailability studies of quercetin, kaempferol and isorhamnetin after oral administration of Ginkgo biloba extracts, Ginkgo biloba extract phospholipid complexes and Ginkgo biloba extract solid dispersions in rats.
    Chen ZP; Sun J; Chen HX; Xiao YY; Liu D; Chen J; Cai H; Cai BC
    Fitoterapia; 2010 Dec; 81(8):1045-52. PubMed ID: 20603197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Target profiling of flavonol glycosides in the extract of Ginkgo biloba leaf and their pharmacokinetics in rat plasma by ultra-high-performance liquid chromatography with tandem mass spectrometry.
    Qu C; Wen JH; Li P; Gao W; Yang H
    J Sep Sci; 2022 Feb; 45(3):728-738. PubMed ID: 34841683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Ginkgo biloba supplements adulteration using high performance thin layer chromatography and ultra high performance liquid chromatography-diode array detector-quadrupole time of flight-mass spectrometry.
    Avula B; Sagi S; Gafner S; Upton R; Wang YH; Wang M; Khan IA
    Anal Bioanal Chem; 2015 Oct; 407(25):7733-46. PubMed ID: 26297458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of two step liquid-liquid extraction tandem UHPLC-MS/MS method for the simultaneous determination of Ginkgo flavonoids, terpene lactones and nimodipine in rat plasma: Application to the pharmacokinetic study of the combination of Ginkgo biloba dispersible tablets and Nimodipine tablets.
    Xiao J; Wang T; Li P; Liu R; Li Q; Bi K
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Aug; 1028():33-41. PubMed ID: 27318642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic herb-disease-drug interactions: Effect of ginkgo biloba extract on the pharmacokinetics of pitavastatin, a substrate of Oatp1b2, in rats with non-alcoholic fatty liver disease.
    Li Z; Tian S; Wu Z; Xu X; Lei L; Li Y; Wang B; Huang Y
    J Ethnopharmacol; 2021 Nov; 280():114469. PubMed ID: 34329714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioavailability of ginkgolides and bilobalide from extracts of ginkgo biloba using GC/MS.
    Biber A; Koch E
    Planta Med; 1999 Mar; 65(2):192-3. PubMed ID: 10193211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid chromatography/electrospray mass spectrometry of bioactive terpenoids in Ginkgo biloba L.
    Mauri P; Migliazza B; Pietta P
    J Mass Spectrom; 1999 Dec; 34(12):1361-7. PubMed ID: 10587633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VERIFICATION OF AUTHENTICITY OF
    Budeč M; Bošnir J; Racz A; Lasić D; Brkić D; Mosović Ćuić A; Kuharić Ž; Jurak G; Barušić L
    Acta Clin Croat; 2019 Dec; 58(4):672-692. PubMed ID: 32595253
    [No Abstract]   [Full Text] [Related]  

  • 20. Quality evaluation of ginkgo biloba leaves based on non-targeted metabolomics and representative ingredient quantification.
    Gao H; Chen X; Li Y; Gao X; Wang J; Qian M; Tong X; Wang S; Wang Y; Feng J; Cao L; Wang Z; Xiao W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Jan; 1214():123549. PubMed ID: 36481725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.